1 | Topical β blockers | YAG laser iridotomy | 6 | 20/300 |
| Topical and systemic carbonic anhydrase inhibitors | | | |
| Topical α adrenergic agonists | | | |
| Hyperosmotic agents | | | |
| Cycloplegia | | | |
| Topical steroids | | | |
2 | Topical β blockers | YAG laser iridotomy | 10 | 20/80 |
| Systemic carbonic anhydrase inhibitors | AC washout (for fibrin) | | |
| Hyperosmotic agents | | | |
| Cycloplegia | | | |
| Topical steroids | | | |
3 | Topical β blockers | YAG laser iridotomy (×2) | 6 | 20/150 |
| Topical α adrenergic agonists | | | |
| Xalatan | | | |
4 RE | Topical β1 selective blockers | YAG laser iridotomy (×3) | 30 | 20/120 |
| Topical α adrenergic agonists | | | |
| Pilocarpine 2% | | | |
| Systemic carbonic anhydrase inhibitors | | | |
| Cycloplegia | | | |
4 LE | Topical β2 selective blockers | YAG laser iridotomy | 28 | 1/24 |
| Topical α adrenergic agonists | Anterior vitrectomy+surgical iridectomy (×2) | | |
| Systemic carbonic anhydrase inhibitors | Cyclodiode | | |
5 | Topical β blockers | YAG laser iridotomy | 8 | 20/30 |
| Pilocarpine 2% | | | |
| Systemic carbonic anhydrase inhibitors | | | |
6 | Topical β blockers | YAG laser iridotomy (×2) | 18 | 20/150 |
| Topical α adrenergic agonists | YAG laser capsulotomy | | |
| Topical carbonic anhydrase inhibitors | | | |